Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 440-240-7 | CAS number: 1282554-35-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011-01-13 to 2011-0602
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: According to OECD 474 and GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- (1997)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- other: US EPA Pesticide Assessment Guidelines Subdivision F Series 84-2
- Qualifier:
- according to guideline
- Guideline:
- other: ICH Guidelines and Japanese MHLW Guidelines on Genotoxicity Testing (Notification No. 1604 of the Pharmaceutical Affair Bureau of MHW, November 1st, 1999)
- Qualifier:
- according to guideline
- Guideline:
- other: recommendations published by the US Environmental Protection Agency Gene-Tox Program and the Japanese Collaborative Study Group for Micronucleus Testing (Mavournin et al, 1990; CSGMT/JEMS.MMS, 1990)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 2-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole
- IUPAC Name:
- 2-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Storage condition of test material: at ambient temperature and dark.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Source: Charles River UK, (Margate, CT9 4LT, UK); female and male CD-1 mice CD (Crl:CD-1)- Age at study initiation: 7 weeks- Weight at study initiation: male 30.3 - 38.8 g, female 24.1 - 28.1 g- Assigned to test groups randomly: yes- Housing: individually- Diet (e.g. ad libitum): ad libitum, except for 2-4 h prior to dosing and 1-2 h after dosing- Water (e.g. ad libitum): ad libitum- Acclimation period: no dataENVIRONMENTAL CONDITIONS- Temperature (°C): 17.6 - 22.4 °C- Humidity (%): 30 - 68%- Air changes (per hr): at least 15 air changes per hour- Photoperiod (hrs dark / hrs light): 12 h light/dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: carboxymethyl cellulose (1%, w/w, 10 mL/kg/day)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:The test item was dissolved in 1% CMC to give the required dosing concentrations, as near to the time of dosing as practicable. The dose volume used for both the vehicle control and test item treated animals was a constant 10 mL/kg body weight.Cyclophosphamide was prepared fresh as a solution in water for irrigation (5 mg/mL). It was administered to the positive control animals in dose volumes of 10 mL/kg to give the required target dose of 50 mg/kg.All formulations were dosed within 2 h of preparation with the exception of toxicity group 4 on day 1.
- Frequency of treatment:
- at 0 h and 24 h
- Post exposure period:
- marrow samples taken 24 h after the last treatment
Doses / concentrations
- Remarks:
- Doses / Concentrations:50, 100, 200 mg/kg/dayBasis:actual ingested
- No. of animals per sex per dose:
- vehicle control: 5 males and 5 females50 mg/kg: 5 males100 mg/kg: 5 males200 mg/kg: 8 males and 8 femalespositive control: 3 males
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide- Route of administration: oral- Doses: 50 mg/kg/day orally dosed at 0h and 24 h
Examinations
- Tissues and cell types examined:
- Bone Marrow - Erythrocytes (normochromatic cells and polychromatic cells)
- Details of tissue and slide preparation:
- Mice were humanely killed by an appropriate method and one femur from each mouse was quickly dissected out and freed of adherent tissue. A small hole was made in the neck of one femur and the marrow flushed, using a syringe fitted with a hypodermic needle, into a centrifuge tube containing a 1:1 (v/v) mixture of foetal calf serum and trisodium citrate (0.8%, w/v) in Sorensen's buffer, (pH 6.8).The tubes were centrifuged to pellet the cells. All but a few drops of supernatant fluid were discarded. The cells were then resuspended on a vortex mixer in this residual amount of supernatant liquid.DETAILS OF SLIDE PREPARATION:Clean slides were assigned numbers corresponding to the tube numbers. A drop of the suspension was placed at one end of the slide and a smear made by drawing the top of a Pasteur pipette horizontally along the slide. Two slides were prepared from each tube/animal. The smear was left to air dry, fixed in methanol and then stained in Giemsa stain (15%, v/v), to give optimum erythrocyte discrimination.The stained smears were gently rinsed in water for and left to air dry. Permanent slide preparations were made by sealing coverslips onto the glass slides using DPX mounting medium.METHOD OF ANALYSIS:One of the prepared slides for every animal was selected for examination and the coded slides assessed blind by the same operator. At least two thousand (2000) polychromatic erythrocytes (PCE) per animal were scored for micronuclei and the frequency of micronucleated cells (MN-PCE) determined.As a control against inclusion of artefacts, or action of a mutagen on the G2 and/or mitotic phase of the cell cycle, the numbers of micronucleated normochromatic erythrocytes (MN-NCE) in mature red blood corpuscles were also recorded. In addition, scored micronuclei were assigned on the basis of size into small or large categories, historically defined as micronuclei occupying less or more than 25% of the visible cellular area. This classification provided a non-specific measure of compound induced spindle dysfunction, as large micronuclei appear to derive from lagging chromosomes caused by damage to the mitotic apparatus during bone marrow erythropoiesis.The PCE/NCE ratio, a measure of any induced systemic toxicity, was determined by counting a minimum total of 1000 erythrocytes (PCE + NCE) per marrow preparation.A suitable binocular microscope was used for the assessment. The scoring was done under a nominal magnification of x 1250 using x 12.5 magnification eye pieces and a x 100 oil immersion objective.
- Evaluation criteria:
- refer to "Any other information on materials and methods incl. tables"
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
Any other information on results incl. tables
Animal Observations:
No animal deaths occurred in the main micronucleus test. No animals displayed signs of toxicity.
Vehicle Control Group:
The numbers of micronucleated bone marrow polychromatic erythrocytes (MN-PCE) in mice dosed with the vehicle 1% CMC (10 mL/kg/day), averaged 0.05%. This MN-PCE frequency conformed to the established in-house control range for vehicle treated mice (0.00-0.23% per 5 mice or 0.00-0.18% per 10 mice).
Positive Control Group:
Exposure of mice to the positive control agent cyclophosphamide (50 mg/kg/day), induced large increases in bone marrow micronuclei. The mean MN-PCE frequency for the mice was 1.47%. An evident increase in the number of MN-NCE was also observed. Bone marrow toxicity accompanied these findings as shown by a suppression of the PCE/NCE ratios.
Test Item Group:
There was no indication that the test substance induced bone marrow micronuclei in the treated mice. The highest MN-PCE frequency recorded for the test item was in the mid dose where an incidence of 0.08% was observed. There was no indication of bone marrow toxicity in any of the test item dose groups.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negativeThe test item did not induce micronuclei in bone marrow cells when tested to the maximum tolerated dose of 200 mg/kg/day in male and female CD-1 mice using a 0 h and 24 h oral dosing and 48 h sampling regimen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.